Solstein Capital, LLC

SEC CIK: 0001730769
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Solstein Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 69
Value: $43.0K
% of portfolio: <0.1%
Quarters held: 22; Since Q1 2021

Holdings of REGN by Solstein Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	69	$43.0K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	69	$53.3K	<0.1%	−2−2.8%	Reduced	Holders
Q4 2025	71	$54.8K	<0.1%	−137−65.9%	Reduced	Holders
Q3 2025	208	$117.0K	0.1%	−40−16.1%	Reduced	Holders
Q2 2025	248	$130.2K	0.1%	−41−14.2%	Reduced	Holders
Q1 2025	289	$183.3K	0.1%	−10−3.3%	Reduced	Holders
Q4 2024	299	$213.0K	0.1%	00.0%	Unchanged	Holders
Q3 2024	299	$314.3K	0.2%	00.0%	Unchanged	Holders
Q2 2024	299	$314.3K	0.2%	−72−19.4%	Reduced	Holders
Q1 2024	371	$357.1K	0.2%	00.0%	Unchanged	Holders
Q4 2023	371	$325.8K	0.2%	00.0%	Unchanged	Holders
Q3 2023	371	$305.3K	0.3%	−12−3.1%	Reduced	Holders
Q2 2023	383	$275.2K	0.2%	+30+8.5%	Added	Holders
Q1 2023	353	$290.1K	0.3%	+89+33.7%	Added	Holders
Q4 2022	264	$190.5K	0.2%	−16−5.7%	Reduced	Holders
Q3 2022	280	$193.0K	0.2%	+5+1.8%	Added	Holders
Q2 2022	275	$163.0K	0.1%	−5−1.8%	Reduced	Holders
Q1 2022	280	$196.0K	0.1%	−738−72.5%	Reduced	Holders
Q4 2021	1,018	$643.0K	0.4%	+969+1,977.6%	Added	Holders
Q3 2021	49	$30.0K	<0.1%	00.0%	Unchanged	Holders
Q2 2021	49	$27.0K	<0.1%	+2+4.3%	Added	Holders
Q1 2021	47	$22.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.